ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 37 (3) , 324-339.e8
Abstract
No abstract availableKeywords
Funding Information
- National Key Research and Development Program of China Stem Cell and Translational Research
- National Natural Science Foundation of China
This publication has 38 references indexed in Scilit:
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine, 2012
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- A scaling normalization method for differential expression analysis of RNA-seq dataGenome Biology, 2010
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumorsProceedings of the National Academy of Sciences, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR PathwayCell, 2007
- Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4Nature, 2006
- RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosisCancer Biology & Therapy, 2005
- Purine suppression of proliferation of Sertoli‐like TM4 cells in cultureCell Proliferation, 1995
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994